Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancer
The most frequently mentioned effects fall into a mild and self-limiting category
When AMPK is activated, it may trigger metabolic effects including improved insulin sensitivity, enhanced glucose uptake by cells, and reduced glucose production in the liver
Ongoing clinical trials are actively unveiling insights into the prospective applications of IPN60090 in cancer therapy, shedding light on its potential therapeutic significance (NCT03894540, NCT05039801)
US$ 21.05
US$ 23.78
US$ 23.03
